Evercore ISI Group Maintains Outperform on Medtronic, Lowers Price Target to $105

Benzinga Newsdesk www.benzinga.com Negative 94.7%

Neg 94.7% Neu 0% Pos 0%

Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lowers the price target from $106 to $105.